trimetazidine has been researched along with transforming growth factor beta in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, X; He, X; Jiang, P; Li, W; Sun, Y; Wang, X; Zhang, J; Zhang, Y | 1 |
| Ding, W; Qian, J; Tang, L; Yang, L; Zhang, S; Zhou, D | 1 |
| Chen, X; Dong, T; Du, L; Lin, Z; Xia, X; Zhou, H | 1 |
3 other study(ies) available for trimetazidine and transforming growth factor beta
| Article | Year |
|---|---|
Protective effect of trimetazidine in radiation-induced cardiac fibrosis in mice.
Topics: Animals; Connective Tissue Growth Factor; Fibrosis; Gene Expression Regulation; Male; Mice, Inbred C57BL; Myocardium; Radiation-Protective Agents; RNA, Messenger; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta; Trimetazidine | 2020 |
Trimetazidine inhibits liver fibrosis and hepatic stellate cell proliferation and blocks transforming growth factor-β (TGFβ)/Smad signaling
Topics: Animals; Cell Proliferation; Hepatic Stellate Cells; Liver; Liver Cirrhosis; Mice; Smad Proteins; Transforming Growth Factor beta; Transforming Growth Factors; Trimetazidine | 2022 |
Trimetazidine Reduces Cardiac Fibrosis in Rats by Inhibiting NOX2-Mediated Endothelial-to-Mesenchymal Transition.
Topics: Animals; Cardiomyopathies; Epithelial-Mesenchymal Transition; Fibrosis; Human Umbilical Vein Endothelial Cells; Humans; NF-kappa B; Rats; Rats, Sprague-Dawley; Stroke Volume; Transforming Growth Factor beta; Trimetazidine; Ventricular Function, Left | 2022 |